Chinese Medicine(Hu Yang Yang Kun Formula) for Primary Ovarian Insufficiency
NCT02794948 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 48
Last updated 2018-04-10
Summary
The purpose of this research is providing valuable traditional chinese medicine theory and formula in treating Primary Ovarian insufficiency.
Conditions
- Primary Ovarian Insufficiency
Interventions
- OTHER
-
Chinese medicine granules (HuYang Yang Kun Formula)
Take Chinese medicine granules (HuYang Yang Kun Formula), 1 sack every time,twice a day Take DHEA(dehydroepiandrosterone) placebo,1 capsule every time ,once a day. Treatment for 3 months Both Chinese Medicine formula granules and DHEA placebo were produced by Jiangyin Medical \&pharmaceutical limited company in Jiangsu province
- DIETARY_SUPPLEMENT
-
dehydroepiandrosterone
The DHEA( dehydroepiandrosterone)25mg,1 capsule every time once a day. Take Chinese medicine granules placebo , 1 sack every time,twice a day Treatment is 3 months. DHEA were produced by General Nutrition Center(GNC)company in America and The placebo granules of Chinese Medicine were produced by Jiangyin Medical \&pharmaceutical limited company in Jiangsu province.
Sponsors & Collaborators
-
Guangzhou University of Traditional Chinese Medicine
lead OTHER
Principal Investigators
-
Hongyan Yang, professor · Guangzhou University of Traditional Chinese Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-04-30
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
Countries
- China
Study Locations
More Related Trials
-
Effects of Acupuncture on Ovarian Function and Pregnancy Outcomes in Women With Decreased Ovarian Reserve
NCT05566210 ·Status: UNKNOWN ·Phase: NA
-
The Effect of DHEA on Markers of Ovarian Reserve in Women With Diminished Ovarian Reserve
NCT01129830 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Effect of Dehydroepiandrosterone Administration in Patients With Poor Ovarian Response According to the Bologna Criteria
NCT02132559 ·Status: COMPLETED
-
Efficacy of Traditional Chinese Medicine on Ameliorating IVF-ET Outcomes of Diminished Ovarian Reserve Patients
NCT05577455 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Trial of Anovulatory Infertility
NCT06601452 ·Status: ENROLLING_BY_INVITATION ·Phase: EARLY_PHASE1
-
Effects of Androgen Administration on Inflammation in Normal Women
NCT01753037 ·Status: COMPLETED ·Phase: NA
-
Effectiveness and Safety of Bushen Culuan Decoction for Anovulatory Infertility
NCT03709849 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Evaluation of Integrated Chinese-Western Medicine for Infertility With DOR Patients in Women Achieving Natural Pregnancy
NCT07296614 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Multicenter Observational Study on the Development and Health Effects of Premature Ovarian Insufficiency
NCT06067529 ·Status: NOT_YET_RECRUITING
-
The Effect of a Higher Dose of Dehydroepiandrosterone (DHEA) Supplementation in Poor Responders
NCT02357472 ·Status: TERMINATED ·Phase: NA
-
Testing Herbal Pretreatment For IVF Success In Women With Low Ovarian Reserve
NCT07347340 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Effects of Dehydroepiandrosterone Supplementation on Cumulus Cells Gene Expression Under Controlled Ovarian Hyper-stimulation in Patients With Diminished Ovarian Reserve
NCT02150330 ·Status: COMPLETED ·Phase: PHASE3
-
Dehydroepiandrosterone (DHEA)Supplementation Pre-IVF(In Vitro Fertilization) Cycles
NCT02866253 ·Status: COMPLETED ·Phase: PHASE4
-
Dehydroepiandrosterone (DHEA) Intervention To Treat Ovarian Aging
NCT01572025 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Gushen Antai Pill on Ongoing Pregnancy Rate in Women With Normal Ovarian Reserve Undergoing IVF-ET
NCT04872660 ·Status: RECRUITING ·Phase: PHASE4
-
A Clinical Study of Chinese Herbal Compound TJAOA101 in the Treatment of Premature Ovarian Insufficiency
NCT05522634 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
The Effect of Growth Hormone in Assisted Reproductive Technology Clinical Outcome of Poor Responder
NCT03027843 ·Status: UNKNOWN ·Phase: PHASE4
-
A Clinical Study of Chinese Herbal Compound TJAOA101 in Therapy of Diminished Ovarian Reserve
NCT05459493 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Clinical Study of Baozhu Keli in the Treatment of Ovarian Aging
NCT06256783 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Electroacupuncture for Diminished Ovarian Reserve
NCT02229604 ·Status: COMPLETED ·Phase: PHASE1
-
Stem Cell Therapy Combined Hormone Replacement Therapy in Patients With Premature Ovarian Failure
NCT01742533 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study of Dehydroepiandrosterone Treatment for Poor Responders in In Vitro Fertilization Patients
NCT01535872 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Growth Hormone Injection on the IVF/ICSI Outcome of Patients With Poor Ovarian Reserve.
NCT04588844 ·Status: UNKNOWN ·Phase: NA
-
Effect of Electro-acupuncture on Women With Diminished Ovarian Reserve
NCT04972877 ·Status: RECRUITING ·Phase: NA
-
Effect of 12 Weeks of Acupuncture on AMH and COH in Low Responder Patients
NCT03080584 ·Status: UNKNOWN ·Phase: NA